Executive Chairman of Genomic Health Inc. (GHDX, Financial) Randal W Scott sells 20,000 shares of GHDX on 03/11/2011 at an average price of $25.62 a share.
Genomic Health Inc. has a market cap of $734.99 million; its shares were traded at around $25.47 with a P/E ratio of 181.93 and P/S ratio of 4.13.
For the complete insider trading history of GHDX, click here.
Genomic Health Inc. has a market cap of $734.99 million; its shares were traded at around $25.47 with a P/E ratio of 181.93 and P/S ratio of 4.13.
CEO Recent Trades:
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 02/15/2011 at the average price of 22.51. Kimberly J Popovits owns at least 319,424 shares after this. The price of the stock has increased by 13.15% since.
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 01/18/2011 at the average price of 21.15. Kimberly J Popovits owns at least 309,424 shares after this. The price of the stock has increased by 20.43% since.
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 01/18/2011 at the average price of 21.15. Kimberly J Popovits owns at least 309,424 shares after this. The price of the stock has increased by 20.43% since.
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 12/16/2010 at the average price of 22.71. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has increased by 12.15% since.
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 11/16/2010 at the average price of 17.5. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has increased by 45.54% since.
CFO Recent Trades:
- Sell: CFO Dean L Schorno sold 1,000 shares of GHDX stock on 02/15/2011 at the average price of 22.51. Dean L Schorno owns at least 29,049 shares after this. The price of the stock has increased by 13.15% since.
- Sell: CFO Dean L Schorno sold 1,276 shares of GHDX stock on 01/13/2011 at the average price of 21.06. Dean L Schorno owns at least 26,149 shares after this. The price of the stock has increased by 20.94% since.
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 12/13/2010 at the average price of 22.64. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has increased by 12.5% since.
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 11/11/2010 at the average price of 18.04. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has increased by 41.19% since.
Directors and Officers Recent Trades:
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 70,856 shares of GHDX stock on 03/10/2011 at the average price of 26.03. Brothers Life Sciences C Baker owns at least 5,674,104 shares after this. The price of the stock has decreased by 2.15% since.
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 349,566 shares of GHDX stock on 03/08/2011 at the average price of 25.06. Brothers Life Sciences C Baker owns at least 5,603,248 shares after this. The price of the stock has increased by 1.64% since.
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 9,648 shares of GHDX stock on 03/08/2011 at the average price of 25.06. Capital (gp), Llc 14159 owns at least 152,640 shares after this. The price of the stock has increased by 1.64% since.
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 4,426 shares of GHDX stock on 03/02/2011 at the average price of 25.69. Capital (gp), Llc 14159 owns at least 142,992 shares after this. The price of the stock has decreased by 0.86% since.
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 160,337 shares of GHDX stock on 03/02/2011 at the average price of 25.69. Brothers Life Sciences C Baker owns at least 5,253,682 shares after this. The price of the stock has decreased by 0.86% since.
For the complete insider trading history of GHDX, click here.
